ArticleScientific reports2026
Application of resting-state EEG theta /alpha power ratio analysis for diagnosing amnestic mild cognitive impairment.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate spectral power and the theta/alpha power ratio of resting-state electroencephalography (EEG) in patients with amyloid-positive amnestic mild cognitive impairment (aMCI) compared to normal controls (NC). Twenty-four patients with aMCI, confirmed by Pittsburgh Compound B positron emission tomography (PiB-PET), and twenty-four age-matched NC participants were included. Resting-state EEG recordings were analyzed for spectral power across delta, theta, alpha, and beta bands. Group comparisons and receiver operating characteristic (ROC) curve analyses, corrected for multiple comparisons using false discovery rate (FDR), were performed to assess diagnostic utility. Compared to NC, patients with aMCI exhibited EEG slowing, characterized by higher power in lower frequency bands and lower power in higher frequency bands. Regional analysis showed that the theta/alpha power ratio in the occipital region provided the best discrimination between groups (area under the curve [AUC] = 0.86), with high sensitivity and specificity (both > 91.7%). These findings indicate that patients with biomarker-confirmed aMCI present distinct, widespread electrophysiological alterations, possibly reflecting underlying neuropathological changes such as cholinergic dysfunction. This study provides a regional, quantitative evaluation of EEG spectral measures and their diagnostic performance in a PiB-PET-characterized aMCI cohort, offering exploratory evidence for the theta/alpha ratio as a potential adjunctive biomarker. Further validation in larger, independent samples is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.